Search

Organon & Co

Cerrado

SectorSanidad

13.52 -0.29

Resumen

Variación precio

24h

Actual

Mínimo

13.51

Máximo

13.57

Métricas clave

By Trading Economics

Ingresos

351M

146M

Ventas

-47M

1.5B

P/B

Media del Sector

14.505

62.58

BPA

0.71

Rentabilidad por dividendo

0.59

Margen de beneficios

10

Empleados

10,000

EBITDA

344M

409M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+3.55% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

0.59%

2.19%

Próximas Ganancias

4 ago 2026

Fecha Próximo Dividendo

10 sept 2026

Próxima Fecha de Ex Dividendo

14 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

87M

3.5B

Apertura anterior

13.81

Cierre anterior

13.52

Noticias sobre sentimiento de mercado

By Acuity

47%

53%

123 / 340 Clasificación en Healthcare

Organon & Co Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 jul 2026, 10:46 UTC

Social Media
News

Knight-Swift Transportation reported strong Q2 results, with revenue of $2.1 billion and adjusted EPS of $0.63, but shares are lower in pre-market trading.

23 jul 2026, 10:46 UTC

Social Media
News
Correlated Moves

Northrop Grumman Corp secured a $1.2 billion contract for E-2D aircraft production, boosting shares in pre-market trading amid positive investor sentiment.

23 jul 2026, 10:46 UTC

News

Blackstone Inc has launched two hybrid investment funds to expand access to alternative investments. Shares are trading higher since Wednesday's close, despite earlier losses.

23 jul 2026, 10:46 UTC

News

Barclays lowered Pegasystems' price target to $39.00 from $48.00, maintaining an Overweight rating. Shares are trading lower in pre-market hours.

23 jul 2026, 10:46 UTC

News
Social Media

Intel is finalizing long-term purchase commitments for data-center processors in China, driven by AI demand. Shares are higher in pre-market trading ahead of earnings.

23 jul 2026, 10:46 UTC

News

Geopolitical tensions are impacting the US 10Y Treasury Bond Index. As a result, Vanguard Total Bond Market ETF is trading roughly flat during pre-market hours.

23 jul 2026, 10:46 UTC

News

Community Health Systems shares lower in pre-market after Barclays cut the price target to $2.50, following a decline in net income and revenues.

23 jul 2026, 10:42 UTC

News

Coca-Cola recognized as a top dividend stock, offering a quarterly dividend of $0.53 per share. Shares are higher in pre-market trading.

23 jul 2026, 10:36 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is slightly higher in pre-market trading, supported by strong performances from key holdings, despite broader market caution ahead of the ECB decision.

23 jul 2026, 10:36 UTC

News

Schlumberger NV reports $8.72 billion in quarterly revenue, down 6.3% year-over-year. Shares advance in pre-market trading, supported by positive sector sentiment.

23 jul 2026, 10:36 UTC

Social Media
News

General Motors shares are higher in pre-market trading following strong Q2 results and price target increases from TD Cowen and Goldman Sachs.

23 jul 2026, 10:32 UTC

Social Media
News

Hewlett Packard Enterprise shares are higher in pre-market trading, supported by strong investor interest in AI infrastructure and positive sector sentiment following Dell's gains.

23 jul 2026, 10:26 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF trades roughly flat in pre-market hours as major tech firms prepare to report quarterly earnings, influencing investor focus on AI and cloud growth.

23 jul 2026, 10:26 UTC

News

Fortinet Inc. has been named Intel's first external customer for its foundry business, producing the SP6 security chip. Shares are higher in pre-market hours.

23 jul 2026, 10:26 UTC

News
Correlated Moves

ConocoPhillips shares are higher in pre-market trading, reflecting a positive response to rising WTI crude prices amid escalating Middle East tensions.

23 jul 2026, 10:26 UTC

News

Nasdaq Inc is advancing in pre-market trading as it prepares to implement new delisting rules for underperforming microcap companies following SEC approval.

23 jul 2026, 10:16 UTC

News

PagSeguro Digital shares are lower in pre-market trading following Jefferies' Hold rating and price target of $10.40, after closing at $9.67.

23 jul 2026, 10:16 UTC

News
Event

Arrowhead Pharmaceuticals shares rise in pre-market trading, building on Wednesday's gains after positive drug trial results and a price target increase to $115 from $90.

23 jul 2026, 10:16 UTC

News

DigitalOcean Holdings sees strong demand for AI data centers, with $800 million in remaining performance obligations. Shares are higher in pre-market trading.

23 jul 2026, 10:16 UTC

News

American Electric Power shares are lower in pre-market trading amid ongoing performance weakness, despite the appointment of two new board members.

23 jul 2026, 10:16 UTC

Social Media
News

Netflix Inc. shares are higher in pre-market trading, supported by strong Movies & Entertainment sector performance and robust EBITDA of $8.66 billion.

23 jul 2026, 10:16 UTC

News
Social Media

Advanced Micro Devices is finalizing long-term CPU commitments in China, driven by AI demand. Shares are higher in pre-market trading amid these developments.

23 jul 2026, 10:16 UTC

Social Media
News
Correlated Moves

Apple Inc shares are lower in pre-market trading amid a broader market downturn and challenges in foldable iPhone production, though the launch schedule remains on track.

23 jul 2026, 10:11 UTC

News

Autodesk shares rise in pre-market after Guggenheim Buy rating.

23 jul 2026, 10:11 UTC

News

Southwest Airlines shares are lower in pre-market trading after the company issued third-quarter guidance below consensus and revised full-year EPS expectations downward.

23 jul 2026, 10:11 UTC

News

American Airlines shares are trading lower in pre-market hours as higher jet fuel costs weigh on earnings projections ahead of upcoming results.

23 jul 2026, 10:11 UTC

Social Media
News

Kinder Morgan shares are higher in pre-market trading following strong second-quarter results, including record net income of $867 million and a dividend increase to $0.2975.

23 jul 2026, 10:11 UTC

News

Teledyne Technologies announced a five-year partnership with the Royal National Lifeboat Institution to enhance lifeboat technology. Needham raised its price target to $750.

23 jul 2026, 10:06 UTC

Social Media
News

Micron Technology shares higher in pre-market trading following a Motley Fool prediction of $1,400 by 2027, citing strong revenue growth and strategic agreements.

23 jul 2026, 10:06 UTC

News

EQT Corp's stock rises in pre-market trading after raising full-year natural gas production guidance and securing long-term supply agreements.

Comparación entre iguales

Cambio de precio

Organon & Co previsión

Precio Objetivo

By TipRanks

3.55% repunte

Estimación a 12 Meses

Media 14 USD  3.55%

Máximo 14 USD

Mínimo 14 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Organon & Co Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

2 ratings

0

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

123 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
help-icon Live chat